America November 19, 2025
Pfizer, Tris Pharma Reach $41.5M Settlement in Texas ADHD Drug Fraud Suit
Pharmaceutical giant Pfizer Inc. and Tris Pharma Inc. agreed Wednesday to pay $41.5 million to resolve explosive claims by the…
America November 19, 2025
Pharmaceutical giant Pfizer Inc. and Tris Pharma Inc. agreed Wednesday to pay $41.5 million to resolve explosive claims by the…
By Rihem Akkouche
America November 4, 2025
In a dramatic twist in the Pfizer Weight-Loss $9B suit, a Delaware vice chancellor on Tuesday denied Pfizer Inc.’s emergency…
By Rihem Akkouche
America November 1, 2025
In a dramatic escalation of a high-stakes biopharma showdown, Pfizer Inc. has filed suit in Delaware Chancery Court to stop…
By Rihem Akkouche
America October 30, 2025
In a bold and unexpected twist in the pharmaceutical merger arena, Metsera Inc. announced Thursday that Novo Nordisk has submitted…
By Rihem Akkouche
America September 22, 2025
Pfizer Inc. is making a daring return to the obesity battlefield, announcing Monday that it will acquire Metsera Inc. for…
By Rihem Akkouche
America January 27, 2025
The U.S. Supreme Court on Monday declined to review a Second Circuit decision holding that consolidated lawsuits against pharmaceutical companies…
By Rihem Akkouche
America August 23, 2024
Connecticut state court litigation can move ahead for two groups of plaintiffs alleging that Zantac causes cancer and suing GlaxoSmithKline…
By Rihem Akkouche
America June 5, 2024
Lawsuits claiming Zantac and its generic equivalents caused cancer belong in Connecticut state court, two groups of Constitution State cancer…
By Rochdi Rais
America June 5, 2024
Pharmaceutical companies urged the U.S. Supreme Court on Tuesday to heed the federal government’s suggestion to throw out a D.C.…
By Rochdi Rais
America June 2, 2024
A Delaware judge has allowed more than 70,000 lawsuits regarding the discontinued heartburn drug Zantac to move forward. This decision,…
By Rihem Akkouche